Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weight-Based Torsemide Dosing vs. Standard Outpatient Management in Subjects With Heart Failure: A Randomized Open-Label Pilot Study

NCT03187509 is registered in ClinicalTrials.gov with New York City Health and Hospitals Corporation as lead sponsor.

NCT NCT03187509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03187509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weight-Based Torsemide Dosing vs. Standard Outpatient Management in Subjects With Heart Failure: A Randomized Open-Label Pilot Study
Lead sponsor
New York City Health and Hospitals Corporation
Phase
Phase 4
Overall status
Completed
Start date
April 17, 2018
Completion date
March 14, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure